Abstract
Introduction 37
Tropomyosin receptor kinase A (TrkA), a receptor tyrosine kinase, plays an 38 essential role in neuron survival and/or differentiation in the central nervous system as 39 well as in neural crest-derived cells. A neurotrophin, nerve growth factor (NGF), binds 40 to the TrkA extracellular domain and induces TrkA dimerization and 41 autophosphorylation (1). Aberrant TrkA activity is known to be associated with various 42 diseases including Alzheimer's disease, cancer and depression (2, 3). Therefore, TrkA 43 has been one of the main drug screening targets for these diseases (4). TrkA expressed 44 in mammalian cells or Escherichia coli has been used for analysis of ligand-TrkA 45
interactions (5-8). 46
Prokaryotic hosts like E. coli are typically preferred for recombinant protein 47 expression, owing to their fast growth and ease of genetic engineering (9). However, the 48 expression of the full-length receptor tyrosine kinase often causes the formation of 49 inclusion bodies and toxic effects on prokaryotic hosts. Therefore, only the extracellular 50 region of TrkA has been expressed in E. coli, for ligand-binding analysis (10, 11 of a protein mimicking full-length receptor tyrosine kinase (13). In this system, the 57 intracellular and extracellular regions are separately expressed in different expression 58 systems and joined in vitro by EPL. However, this approach also fails to prepare 59 complete full-length receptor tyrosine kinase. The production of functional full-length 60
TrkA in prokaryotic hosts remains a major experimental challenge. 61
As reported previously, we have developed a novel expression system for 62 human proteins in a prokaryotic host, Magnetospirillum magneticum AMB-1. The 63 genus Magnetospirillum is comprised of gram-negative bacteria that possess unique 64 organelles known as magnetosomes, which are arranged intracellularly in chains (10-65 20 magnetosomes in length). Each magnetosome consists of a nano-sized magnetite 66 particle (50-100 nm) surrounded by a lipid bilayer membrane (14). Mms13 (MamC), a 67 protein known to tightly bind to the magnetite core, is integrated into the membrane on 68 the magnetite surface (15). Target proteins can be efficiently expressed on 69 magnetosomes using Mms13 as a fusion partner (16). The expression system of target 70 proteins onto magnetosomes using Mms13, which we call "magnetosome-display 71 Industries, Osaka, Japan). Image analysis was performed using ImageJ 1.45s software. 134
Analysis of TrkA expression by enzyme-linked immunosorbent assay (ELISA) 135
Magnetosomes (50 μg) were mixed with 1 μg of ALP-conjugated anti-FLAG 136
IgG or ALP-conjugated anti-c-Myc IgG antibody (Acris Antibodies GmBH, Herford, 137
Germany) in 1 ml of PBS-T, and incubated for 30 min at room temperature. The 138 mixture was dispersed using pulsed sonication every 10 min. The magnetosomes were 139 then magnetically separated and washed with 100 μl of PBS-T. Magnetosomes were 140 resuspended in 50 μl of PBS, followed by the addition of 50 μl of Lumi-Phos 530 141 (Wako Pure Chemical Industries). After 5 min of incubation, the luminescence 142 intensities were measured using a microplate reader (Corona Electric, Ibaraki, Japan). Tween-20, pH 7.4) for 1 h at room temperature. After washing them with TBS-T, 168 magnetosomes were incubated in 1 μg/ml goat ALP-conjugated anti-rabbit IgG 169 antibody (Sigma-Aldrich) for 1 h at room temperature. The luminescent intensities were 170 measured as described above. 171
Kinase activity assay 172
TrkA kinase activity on magnetosomes was measured using the CycLex TrkA 173
Kinase Assay/Inhibitor Screening Kit (CycLex Inc., Nagano, Japan) according to 174 the manufacturer's protocol. In brief, magnetosomes (100 μg) were suspended in 100 μl 175 of kinase buffer containing 62.5 μM ATP and added to a kinase substrate 176 peptide-conjugated 96-well microtiter plate. The plate was incubated for 15-120 min at 177 30°C. Samples were mixed every 10 min. After magnetosomes were magnetically 178 
Results and Discussion 186

Expression and topological analysis of TrkA on magnetosomes 187
Membrane proteins were extracted from magnetosomes, and then the 188 Mms13-TrkA fusion protein was detected using western blotting. The protein bands 189 were detected in the expected size (Fig. S1) higher than that from wild-type magnetosomes (Fig. 2(A) & (B) ). These results 202 indicated that both N-and C-termini of TrkA were accessible to the antibodies, and 203 full-length TrkA was localized on the surface of magnetosomes (Fig. 2(C)) . 204
NGF binding analysis of TrkA-magnetosome 205
The ligand-binding activity of TrkA on magnetosomes was assessed using 206 NGF as a ligand and ALP-conjugated anti-NGF antibody (Fig. 3) . The 207
TrkA-magnetosomes were prepared in the presence (reducing conditions; closed circles) 208 and absence (non-reducing conditions; open circles) of DTT during the magnetosome 209 purification process (see experimental procedure in Fig. 1(B) ). The binding of NGF to 210
TrkA-magnetosomes increased in a dose-dependent manner, reaching a plateau at NGF 211 concentrations of more than 50 μM under both reducing and non-reducing conditions 212 (Fig. 3(A) ). Increased binding activity was observed in the presence of DTT (Fig. 3(A) ; 
